SlideShare ist ein Scribd-Unternehmen logo
1 von 4
Val	
  in	
  Crs
MAT MTH Val	
  (Cr) MS% GR% Val	
  (Cr) MS% GR% CORPORATE
80565 100.00 9.1 7738 100.00 18.8 IPM
1 1 5030 6.24 5.8 467 6.03 16.7 Abbott	
  +	
  Abbott	
  HC	
  +	
  Novo
2 3 4343 5.39 15.0 378 4.89 8.9 Sun	
  Pharma
3 2 4038 5.01 10.3 427 5.51 38.4 Cipla
4 4 3480 4.32 8.0 312 4.03 12.0 Zydus	
  +	
  Biochem
5 7 2908 3.61 4.9 273 3.53 15.8 Ranbaxy
6 5 2899 3.60 10.2 305 3.95 30.9 Mankind
7 6 2887 3.58 13.8 290 3.75 19.1 Alkem	
  +	
  Cachet	
  +	
  Indchemie
8 8 2729 3.39 -­‐11.1 264 3.41 14.9 Glaxo
9 9 2710 3.36 12.8 259 3.35 19.7 Lupin
10 12 2348 2.91 6.3 229 2.96 23.9 Pfizer
11 10 2279 2.83 21.4 244 3.15 44.2 Macleods
12 14 2193 2.72 11.1 191 2.47 4.9 Emcure	
  +	
  Zuventus
13 13 2098 2.60 15.3 195 2.51 18.8 Intas
14 11 2023 2.51 19.9 230 2.98 39.7 Aristo
15 16 1984 2.46 -­‐0.5 180 2.32 13.2 Sanofi	
  India
16 18 1779 2.21 5.4 167 2.15 18.4 Torrent
17 15 1754 2.18 16.6 185 2.39 27.0 Glenmark
18 17 1719 2.13 9.4 167 2.15 17.5 Dr.	
  Reddys
19 20 1616 2.01 12.0 143 1.85 4.6 Micro	
  +	
  Bal
20 19 1470 1.82 24.7 152 1.96 22.1 Ipca
21 21 1466 1.82 10.0 128 1.66 7.6 USV
22 23 1145 1.42 -­‐1.0 105 1.36 13.4 Novartis
23 22 1103 1.37 12.8 117 1.51 30.6 Alembic
24 25 993 1.23 6.1 84 1.09 7.6 Wockhardt
25 24 843 1.05 6.8 90 1.16 24.0 FDC
26 26 815 1.01 10.7 77 0.99 13.0 Unichem
27 27 794 0.99 12.9 70 0.90 10.0 MSD	
  +	
  Fulford	
  +	
  Organon
28 29 687 0.85 16.0 60 0.78 9.6 Cadila
29 28 633 0.79 13.4 68 0.88 34.4 Indoco	
  Remedies
30 30 590 0.73 12.5 56 0.73 13.1 Franco
31 31 581 0.72 18.1 49 0.64 12.2 Eris
32 33 491 0.61 8.3 48 0.62 17.2 Himalaya
33 32 483 0.60 10.4 48 0.62 21.6 Merck
34 34 441 0.55 6.3 47 0.60 27.1 Blue	
  Cross
35 36 441 0.55 16.6 45 0.58 41.5 JB	
  Chemicals
36 38 398 0.49 -­‐6.4 43 0.55 49.9 Bharat	
  Serums
37 47 396 0.49 -­‐0.2 30 0.38 -­‐18.0 Astrazeneca
38 39 391 0.49 22.6 38 0.50 23.9 Meyer	
  Organics
39 40 385 0.48 2.4 37 0.48 12.8 Raptakos,	
  Brett
40 35 384 0.48 50.9 46 0.60 92.5 Akumentis
41 37 373 0.46 16.6 44 0.57 48.2 Hetero
42 43 372 0.46 9.8 35 0.45 12.1 Wallace	
  +	
  Indi	
  Pharma
43 42 353 0.44 16.1 36 0.47 26.9 Medley
44 46 342 0.42 10.8 31 0.40 18.8 Janssen
45 44 338 0.42 2.6 33 0.43 13.6 Win-­‐Medicare
46 45 332 0.41 10.7 32 0.41 14.4 Fourrts
47 49 315 0.39 38.4 28 0.37 35.9 Ajanta
48 48 310 0.39 41.7 29 0.38 22.1 Biocon
With	
  Bonus	
  Units	
  at	
  Full	
  Value
Rank MAT	
  Sep	
  -­‐14 Sep-­‐14
49 41 309 0.38 33.0 36 0.47 62.2 Apex	
  Lab
50 51 301 0.37 5.6 27 0.35 -­‐2.3 Albert	
  David
MAT MTH Val	
  (Cr) MS% GR% Val	
  (Cr) MS% GR%
77530 100.00 9.2 7421 100.00 18.6
1 1 4934 6.36 5.8 457 6.15 16.9
2 3 4241 5.47 14.2 368 4.95 8.1
3 2 3799 4.90 12.6 399 5.38 38.7
4 4 3254 4.20 7.7 292 3.94 11.1
5 7 2799 3.61 5.2 262 3.53 15.8
9 6 2475 3.19 12.1 265 3.57 33.7
7 5 2692 3.47 14.5 270 3.64 20.0
6 8 2704 3.49 -­‐10.1 262 3.53 15.5
8 9 2654 3.42 13.0 254 3.42 20.3
10 11 2298 2.96 6.7 224 3.02 23.9
11 10 2135 2.75 21.2 226 3.05 43.9
12 14 2127 2.74 11.4 184 2.48 4.7
13 13 2070 2.67 15.6 192 2.59 19.0
15 12 1772 2.29 17.4 198 2.67 36.1
14 16 1944 2.51 -­‐0.7 175 2.36 12.5
16 17 1744 2.25 5.7 163 2.20 18.3
17 15 1701 2.19 16.2 179 2.41 26.4
18 18 1682 2.17 8.6 162 2.18 16.7
19 20 1546 1.99 12.5 136 1.83 4.1
21 19 1404 1.81 25.0 145 1.95 22.5
20 21 1460 1.88 10.1 128 1.72 7.8
22 23 1108 1.43 0.0 102 1.38 14.3
23 22 1072 1.38 13.5 114 1.53 31.3
24 25 974 1.26 6.2 83 1.11 7.4
25 24 819 1.06 6.7 87 1.18 24.0
26 26 797 1.03 10.3 75 1.01 12.8
27 27 783 1.01 12.6 68 0.92 9.5
28 29 665 0.86 16.1 58 0.78 9.2
29 28 593 0.76 13.4 63 0.85 33.7
31 30 569 0.73 11.9 54 0.73 12.6
30 31 578 0.74 17.9 49 0.66 12.4
32 32 489 0.63 8.0 48 0.64 17.0
33 33 471 0.61 9.4 46 0.63 21.1
35 36 405 0.52 7.1 42 0.57 26.5
34 35 424 0.55 16.7 43 0.59 42.4
37 37 391 0.50 -­‐6.8 42 0.57 49.5
36 47 392 0.51 -­‐0.6 29 0.40 -­‐17.7
39 39 379 0.49 22.4 37 0.50 23.4
38 40 379 0.49 2.2 37 0.50 12.9
40 34 377 0.49 52.4 46 0.61 94.0
43 38 339 0.44 16.7 40 0.54 46.7
41 43 353 0.46 17.4 34 0.46 22.3
44 42 335 0.43 16.4 34 0.46 26.8
42 45 341 0.44 10.8 31 0.42 18.8
45 44 333 0.43 1.2 33 0.44 13.1
46 46 316 0.41 9.7 30 0.40 12.8
47 49 313 0.40 38.2 28 0.38 35.8
48 48 310 0.40 41.7 29 0.39 22.1
Without	
  Bonus	
  Units
Rank MAT	
  Sep	
  -­‐14 Sep-­‐14
49 41 300 0.39 33.1 35 0.48 64.3
50 51 295 0.38 5.4 27 0.36 -­‐2.8

Weitere ähnliche Inhalte

Was ist angesagt?

Golf quotes from the pros
Golf quotes from the prosGolf quotes from the pros
Golf quotes from the prosBarb Oliver
 
LISTA DOS APROVADOS NO CONCURSO DA POLÍCIA MILITAR DE PERNAMBUCO
LISTA DOS APROVADOS NO CONCURSO DA POLÍCIA MILITAR DE PERNAMBUCOLISTA DOS APROVADOS NO CONCURSO DA POLÍCIA MILITAR DE PERNAMBUCO
LISTA DOS APROVADOS NO CONCURSO DA POLÍCIA MILITAR DE PERNAMBUCOIsaquel Silva
 
LISTA 02 – FAMÍLIAS COM PESSOAS COM DEFICIÊNCIA; #POCONET
LISTA 02 – FAMÍLIAS COM PESSOAS COM DEFICIÊNCIA; #POCONETLISTA 02 – FAMÍLIAS COM PESSOAS COM DEFICIÊNCIA; #POCONET
LISTA 02 – FAMÍLIAS COM PESSOAS COM DEFICIÊNCIA; #POCONETJulio Fontes
 
Vereador Divulga nova lista do Auxílio Social
Vereador Divulga nova lista do Auxílio SocialVereador Divulga nova lista do Auxílio Social
Vereador Divulga nova lista do Auxílio SocialAlex Guimarães
 
Vestige Products Presentation
Vestige Products PresentationVestige Products Presentation
Vestige Products PresentationPrasannavijaya
 
Manicure preparations ppt
Manicure preparations pptManicure preparations ppt
Manicure preparations pptVanithaVaniN1
 
Massey ferguson mf 285 s tractors (tr) parts catalogue manual
Massey ferguson mf 285 s tractors (tr) parts catalogue manualMassey ferguson mf 285 s tractors (tr) parts catalogue manual
Massey ferguson mf 285 s tractors (tr) parts catalogue manualfjjsekwsxkdmmem
 
Psoriasis: Natural Product and Phytomedicine
Psoriasis: Natural Product and Phytomedicine Psoriasis: Natural Product and Phytomedicine
Psoriasis: Natural Product and Phytomedicine D.R. Chandravanshi
 
POST HARVEST MANAGEMENT AND VALUE ADDITION
POST HARVEST MANAGEMENT AND VALUE ADDITIONPOST HARVEST MANAGEMENT AND VALUE ADDITION
POST HARVEST MANAGEMENT AND VALUE ADDITIONDILEEP_DS
 
Hyundai r55 w 7 wheel excavator service repair manual
Hyundai r55 w 7 wheel excavator service repair manualHyundai r55 w 7 wheel excavator service repair manual
Hyundai r55 w 7 wheel excavator service repair manualiekkdmmem
 
Best roulette cheat sheet
Best roulette cheat sheetBest roulette cheat sheet
Best roulette cheat sheetimproveyourbet
 
Massey Ferguson Mf 8450, 8460 tractor (tier 3) parts catalog
Massey Ferguson Mf 8450, 8460 tractor (tier 3) parts catalogMassey Ferguson Mf 8450, 8460 tractor (tier 3) parts catalog
Massey Ferguson Mf 8450, 8460 tractor (tier 3) parts catalogPartCatalogs Net
 
Massey ferguson mf 290 tractor (fr) service parts catalogue manual (part numb...
Massey ferguson mf 290 tractor (fr) service parts catalogue manual (part numb...Massey ferguson mf 290 tractor (fr) service parts catalogue manual (part numb...
Massey ferguson mf 290 tractor (fr) service parts catalogue manual (part numb...udfujjsejkkem
 
105指考成績人數累計
105指考成績人數累計105指考成績人數累計
105指考成績人數累計中 央社
 
Hyundai hl757 7 a wheel loader service repair manual
Hyundai hl757 7 a wheel loader service repair manualHyundai hl757 7 a wheel loader service repair manual
Hyundai hl757 7 a wheel loader service repair manualudjjjskkkdmm
 
24. Mushroom and quran , A Series of Presentation By Mr Allah Dad Khan Master...
24. Mushroom and quran , A Series of Presentation By Mr Allah Dad Khan Master...24. Mushroom and quran , A Series of Presentation By Mr Allah Dad Khan Master...
24. Mushroom and quran , A Series of Presentation By Mr Allah Dad Khan Master...Mr.Allah Dad Khan
 
Performance of the export sector of Sri Lanka January-December 2016
Performance of the export sector of Sri Lanka January-December 2016Performance of the export sector of Sri Lanka January-December 2016
Performance of the export sector of Sri Lanka January-December 2016EDB
 

Was ist angesagt? (20)

Golf quotes from the pros
Golf quotes from the prosGolf quotes from the pros
Golf quotes from the pros
 
LISTA DOS APROVADOS NO CONCURSO DA POLÍCIA MILITAR DE PERNAMBUCO
LISTA DOS APROVADOS NO CONCURSO DA POLÍCIA MILITAR DE PERNAMBUCOLISTA DOS APROVADOS NO CONCURSO DA POLÍCIA MILITAR DE PERNAMBUCO
LISTA DOS APROVADOS NO CONCURSO DA POLÍCIA MILITAR DE PERNAMBUCO
 
LISTA 02 – FAMÍLIAS COM PESSOAS COM DEFICIÊNCIA; #POCONET
LISTA 02 – FAMÍLIAS COM PESSOAS COM DEFICIÊNCIA; #POCONETLISTA 02 – FAMÍLIAS COM PESSOAS COM DEFICIÊNCIA; #POCONET
LISTA 02 – FAMÍLIAS COM PESSOAS COM DEFICIÊNCIA; #POCONET
 
Petrotrim Pipe Schedules
Petrotrim Pipe SchedulesPetrotrim Pipe Schedules
Petrotrim Pipe Schedules
 
Vereador Divulga nova lista do Auxílio Social
Vereador Divulga nova lista do Auxílio SocialVereador Divulga nova lista do Auxílio Social
Vereador Divulga nova lista do Auxílio Social
 
Vestige Products Presentation
Vestige Products PresentationVestige Products Presentation
Vestige Products Presentation
 
Manicure preparations ppt
Manicure preparations pptManicure preparations ppt
Manicure preparations ppt
 
Massey ferguson mf 285 s tractors (tr) parts catalogue manual
Massey ferguson mf 285 s tractors (tr) parts catalogue manualMassey ferguson mf 285 s tractors (tr) parts catalogue manual
Massey ferguson mf 285 s tractors (tr) parts catalogue manual
 
Psoriasis: Natural Product and Phytomedicine
Psoriasis: Natural Product and Phytomedicine Psoriasis: Natural Product and Phytomedicine
Psoriasis: Natural Product and Phytomedicine
 
POST HARVEST MANAGEMENT AND VALUE ADDITION
POST HARVEST MANAGEMENT AND VALUE ADDITIONPOST HARVEST MANAGEMENT AND VALUE ADDITION
POST HARVEST MANAGEMENT AND VALUE ADDITION
 
Hyundai r55 w 7 wheel excavator service repair manual
Hyundai r55 w 7 wheel excavator service repair manualHyundai r55 w 7 wheel excavator service repair manual
Hyundai r55 w 7 wheel excavator service repair manual
 
Best roulette cheat sheet
Best roulette cheat sheetBest roulette cheat sheet
Best roulette cheat sheet
 
Massey Ferguson Mf 8450, 8460 tractor (tier 3) parts catalog
Massey Ferguson Mf 8450, 8460 tractor (tier 3) parts catalogMassey Ferguson Mf 8450, 8460 tractor (tier 3) parts catalog
Massey Ferguson Mf 8450, 8460 tractor (tier 3) parts catalog
 
Massey ferguson mf 290 tractor (fr) service parts catalogue manual (part numb...
Massey ferguson mf 290 tractor (fr) service parts catalogue manual (part numb...Massey ferguson mf 290 tractor (fr) service parts catalogue manual (part numb...
Massey ferguson mf 290 tractor (fr) service parts catalogue manual (part numb...
 
Spice
SpiceSpice
Spice
 
105指考成績人數累計
105指考成績人數累計105指考成績人數累計
105指考成績人數累計
 
Hyundai hl757 7 a wheel loader service repair manual
Hyundai hl757 7 a wheel loader service repair manualHyundai hl757 7 a wheel loader service repair manual
Hyundai hl757 7 a wheel loader service repair manual
 
24. Mushroom and quran , A Series of Presentation By Mr Allah Dad Khan Master...
24. Mushroom and quran , A Series of Presentation By Mr Allah Dad Khan Master...24. Mushroom and quran , A Series of Presentation By Mr Allah Dad Khan Master...
24. Mushroom and quran , A Series of Presentation By Mr Allah Dad Khan Master...
 
Performance of the export sector of Sri Lanka January-December 2016
Performance of the export sector of Sri Lanka January-December 2016Performance of the export sector of Sri Lanka January-December 2016
Performance of the export sector of Sri Lanka January-December 2016
 
E book o-real_segredo_da_lotofacil_2012-parte-2
E book o-real_segredo_da_lotofacil_2012-parte-2E book o-real_segredo_da_lotofacil_2012-parte-2
E book o-real_segredo_da_lotofacil_2012-parte-2
 

Mehr von Anup Soans

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...Anup Soans
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardAnup Soans
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingAnup Soans
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thAnup Soans
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMAnup Soans
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021Anup Soans
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsAnup Soans
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentAnup Soans
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramAnup Soans
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramAnup Soans
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsAnup Soans
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow Anup Soans
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectAnup Soans
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramAnup Soans
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsAnup Soans
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalAnup Soans
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollAnup Soans
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceAnup Soans
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Anup Soans
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 IssueAnup Soans
 

Mehr von Anup Soans (20)

An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
An Infectious Disease Specialist, Dr Mandar Kubal Speaks to Pharma on How it ...
 
Key Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way ForwardKey Challenges Facing Pharma Industry and the Way Forward
Key Challenges Facing Pharma Industry and the Way Forward
 
Trends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and SpendingTrends in Pharma Marketing - Focus and Spending
Trends in Pharma Marketing - Focus and Spending
 
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27thMedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
MedicinMan CEO Roundtable 2021 is here... Saturday, Feb 27th
 
Key Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAMKey Account Management - Time for India Pharma to Adopt KAM
Key Account Management - Time for India Pharma to Adopt KAM
 
MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021MedicinMan Report on Digital Readiness of Indian Pharma 2021
MedicinMan Report on Digital Readiness of Indian Pharma 2021
 
How can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand PatientsHow can Pharma Use Digital to Engage Doctors and Understand Patients
How can Pharma Use Digital to Engage Doctors and Understand Patients
 
Why Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop TalentWhy Indian Pharma Needs to Enable Managers to Develop Talent
Why Indian Pharma Needs to Enable Managers to Develop Talent
 
Digital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification ProgramDigital Excellence Pharma Academy Certification Program
Digital Excellence Pharma Academy Certification Program
 
Digital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification ProgramDigital Excellent Pharma Academy Certification Program
Digital Excellent Pharma Academy Certification Program
 
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family AffairsCOVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
COVID-19 Vaccine Roll Out Plan by Ministry of Health and Family Affairs
 
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
Architecture To Develop Pharma Business Leaders  For Today and Tomorrow  Architecture To Develop Pharma Business Leaders  For Today and Tomorrow
Architecture To Develop Pharma Business Leaders For Today and Tomorrow
 
What is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research ProjectWhat is Indian Pharma Thinking about Digital? A Research Project
What is Indian Pharma Thinking about Digital? A Research Project
 
Digital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification ProgramDigital Excellence Pharma Academy - Webinar & Online Certification Program
Digital Excellence Pharma Academy - Webinar & Online Certification Program
 
Telemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian DoctorsTelemedicine Guidelines for Indian Doctors
Telemedicine Guidelines for Indian Doctors
 
The Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit GhoshalThe Mankind Pharma Story by Dr. Sumit Ghoshal
The Mankind Pharma Story by Dr. Sumit Ghoshal
 
Indian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View PollIndian Pharma and Retail Pharmacies - Sales View Poll
Indian Pharma and Retail Pharmacies - Sales View Poll
 
Healthcare's Future will be Patient Experience
Healthcare's Future will be Patient ExperienceHealthcare's Future will be Patient Experience
Healthcare's Future will be Patient Experience
 
Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan Unethical Practices in Pharma - Interesting Study from Pakistan
Unethical Practices in Pharma - Interesting Study from Pakistan
 
MedicinMan December 2018 Issue
MedicinMan December 2018 IssueMedicinMan December 2018 Issue
MedicinMan December 2018 Issue
 

Indian Pharma Market - Top 50 Ranking for Sep-2014

  • 1. Val  in  Crs MAT MTH Val  (Cr) MS% GR% Val  (Cr) MS% GR% CORPORATE 80565 100.00 9.1 7738 100.00 18.8 IPM 1 1 5030 6.24 5.8 467 6.03 16.7 Abbott  +  Abbott  HC  +  Novo 2 3 4343 5.39 15.0 378 4.89 8.9 Sun  Pharma 3 2 4038 5.01 10.3 427 5.51 38.4 Cipla 4 4 3480 4.32 8.0 312 4.03 12.0 Zydus  +  Biochem 5 7 2908 3.61 4.9 273 3.53 15.8 Ranbaxy 6 5 2899 3.60 10.2 305 3.95 30.9 Mankind 7 6 2887 3.58 13.8 290 3.75 19.1 Alkem  +  Cachet  +  Indchemie 8 8 2729 3.39 -­‐11.1 264 3.41 14.9 Glaxo 9 9 2710 3.36 12.8 259 3.35 19.7 Lupin 10 12 2348 2.91 6.3 229 2.96 23.9 Pfizer 11 10 2279 2.83 21.4 244 3.15 44.2 Macleods 12 14 2193 2.72 11.1 191 2.47 4.9 Emcure  +  Zuventus 13 13 2098 2.60 15.3 195 2.51 18.8 Intas 14 11 2023 2.51 19.9 230 2.98 39.7 Aristo 15 16 1984 2.46 -­‐0.5 180 2.32 13.2 Sanofi  India 16 18 1779 2.21 5.4 167 2.15 18.4 Torrent 17 15 1754 2.18 16.6 185 2.39 27.0 Glenmark 18 17 1719 2.13 9.4 167 2.15 17.5 Dr.  Reddys 19 20 1616 2.01 12.0 143 1.85 4.6 Micro  +  Bal 20 19 1470 1.82 24.7 152 1.96 22.1 Ipca 21 21 1466 1.82 10.0 128 1.66 7.6 USV 22 23 1145 1.42 -­‐1.0 105 1.36 13.4 Novartis 23 22 1103 1.37 12.8 117 1.51 30.6 Alembic 24 25 993 1.23 6.1 84 1.09 7.6 Wockhardt 25 24 843 1.05 6.8 90 1.16 24.0 FDC 26 26 815 1.01 10.7 77 0.99 13.0 Unichem 27 27 794 0.99 12.9 70 0.90 10.0 MSD  +  Fulford  +  Organon 28 29 687 0.85 16.0 60 0.78 9.6 Cadila 29 28 633 0.79 13.4 68 0.88 34.4 Indoco  Remedies 30 30 590 0.73 12.5 56 0.73 13.1 Franco 31 31 581 0.72 18.1 49 0.64 12.2 Eris 32 33 491 0.61 8.3 48 0.62 17.2 Himalaya 33 32 483 0.60 10.4 48 0.62 21.6 Merck 34 34 441 0.55 6.3 47 0.60 27.1 Blue  Cross 35 36 441 0.55 16.6 45 0.58 41.5 JB  Chemicals 36 38 398 0.49 -­‐6.4 43 0.55 49.9 Bharat  Serums 37 47 396 0.49 -­‐0.2 30 0.38 -­‐18.0 Astrazeneca 38 39 391 0.49 22.6 38 0.50 23.9 Meyer  Organics 39 40 385 0.48 2.4 37 0.48 12.8 Raptakos,  Brett 40 35 384 0.48 50.9 46 0.60 92.5 Akumentis 41 37 373 0.46 16.6 44 0.57 48.2 Hetero 42 43 372 0.46 9.8 35 0.45 12.1 Wallace  +  Indi  Pharma 43 42 353 0.44 16.1 36 0.47 26.9 Medley 44 46 342 0.42 10.8 31 0.40 18.8 Janssen 45 44 338 0.42 2.6 33 0.43 13.6 Win-­‐Medicare 46 45 332 0.41 10.7 32 0.41 14.4 Fourrts 47 49 315 0.39 38.4 28 0.37 35.9 Ajanta 48 48 310 0.39 41.7 29 0.38 22.1 Biocon With  Bonus  Units  at  Full  Value Rank MAT  Sep  -­‐14 Sep-­‐14
  • 2. 49 41 309 0.38 33.0 36 0.47 62.2 Apex  Lab 50 51 301 0.37 5.6 27 0.35 -­‐2.3 Albert  David
  • 3. MAT MTH Val  (Cr) MS% GR% Val  (Cr) MS% GR% 77530 100.00 9.2 7421 100.00 18.6 1 1 4934 6.36 5.8 457 6.15 16.9 2 3 4241 5.47 14.2 368 4.95 8.1 3 2 3799 4.90 12.6 399 5.38 38.7 4 4 3254 4.20 7.7 292 3.94 11.1 5 7 2799 3.61 5.2 262 3.53 15.8 9 6 2475 3.19 12.1 265 3.57 33.7 7 5 2692 3.47 14.5 270 3.64 20.0 6 8 2704 3.49 -­‐10.1 262 3.53 15.5 8 9 2654 3.42 13.0 254 3.42 20.3 10 11 2298 2.96 6.7 224 3.02 23.9 11 10 2135 2.75 21.2 226 3.05 43.9 12 14 2127 2.74 11.4 184 2.48 4.7 13 13 2070 2.67 15.6 192 2.59 19.0 15 12 1772 2.29 17.4 198 2.67 36.1 14 16 1944 2.51 -­‐0.7 175 2.36 12.5 16 17 1744 2.25 5.7 163 2.20 18.3 17 15 1701 2.19 16.2 179 2.41 26.4 18 18 1682 2.17 8.6 162 2.18 16.7 19 20 1546 1.99 12.5 136 1.83 4.1 21 19 1404 1.81 25.0 145 1.95 22.5 20 21 1460 1.88 10.1 128 1.72 7.8 22 23 1108 1.43 0.0 102 1.38 14.3 23 22 1072 1.38 13.5 114 1.53 31.3 24 25 974 1.26 6.2 83 1.11 7.4 25 24 819 1.06 6.7 87 1.18 24.0 26 26 797 1.03 10.3 75 1.01 12.8 27 27 783 1.01 12.6 68 0.92 9.5 28 29 665 0.86 16.1 58 0.78 9.2 29 28 593 0.76 13.4 63 0.85 33.7 31 30 569 0.73 11.9 54 0.73 12.6 30 31 578 0.74 17.9 49 0.66 12.4 32 32 489 0.63 8.0 48 0.64 17.0 33 33 471 0.61 9.4 46 0.63 21.1 35 36 405 0.52 7.1 42 0.57 26.5 34 35 424 0.55 16.7 43 0.59 42.4 37 37 391 0.50 -­‐6.8 42 0.57 49.5 36 47 392 0.51 -­‐0.6 29 0.40 -­‐17.7 39 39 379 0.49 22.4 37 0.50 23.4 38 40 379 0.49 2.2 37 0.50 12.9 40 34 377 0.49 52.4 46 0.61 94.0 43 38 339 0.44 16.7 40 0.54 46.7 41 43 353 0.46 17.4 34 0.46 22.3 44 42 335 0.43 16.4 34 0.46 26.8 42 45 341 0.44 10.8 31 0.42 18.8 45 44 333 0.43 1.2 33 0.44 13.1 46 46 316 0.41 9.7 30 0.40 12.8 47 49 313 0.40 38.2 28 0.38 35.8 48 48 310 0.40 41.7 29 0.39 22.1 Without  Bonus  Units Rank MAT  Sep  -­‐14 Sep-­‐14
  • 4. 49 41 300 0.39 33.1 35 0.48 64.3 50 51 295 0.38 5.4 27 0.36 -­‐2.8